Free Trial

Cytosorbents (CTSO) Competitors

Cytosorbents logo
$1.04 +0.04 (+4.00%)
Closing price 03:44 PM Eastern
Extended Trading
$1.06 +0.02 (+2.02%)
As of 04:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CTSO vs. NNOX, SNWV, NYXH, ZIMV, SMTI, TCMD, STIM, NVRO, TLSI, and SGHT

Should you be buying Cytosorbents stock or one of its competitors? The main competitors of Cytosorbents include Nano-X Imaging (NNOX), Sanuwave Health (SNWV), Nyxoah (NYXH), ZimVie (ZIMV), Sanara MedTech (SMTI), Tactile Systems Technology (TCMD), Neuronetics (STIM), Nevro (NVRO), TriSalus Life Sciences (TLSI), and Sight Sciences (SGHT). These companies are all part of the "medical equipment" industry.

Cytosorbents vs. Its Competitors

Cytosorbents (NASDAQ:CTSO) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, valuation, dividends, profitability and analyst recommendations.

Cytosorbents has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than Cytosorbents, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cytosorbents$35.60M1.83-$20.72M-$0.28-3.71
Nano-X Imaging$11.28M27.02-$53.52M-$0.90-5.86

Cytosorbents has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500. Comparatively, Nano-X Imaging has a beta of 1.96, meaning that its stock price is 96% more volatile than the S&P 500.

Cytosorbents presently has a consensus price target of $5.50, indicating a potential upside of 428.85%. Nano-X Imaging has a consensus price target of $9.50, indicating a potential upside of 80.09%. Given Cytosorbents' higher probable upside, equities analysts plainly believe Cytosorbents is more favorable than Nano-X Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cytosorbents
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00
Nano-X Imaging
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Cytosorbents had 4 more articles in the media than Nano-X Imaging. MarketBeat recorded 5 mentions for Cytosorbents and 1 mentions for Nano-X Imaging. Cytosorbents' average media sentiment score of 0.09 beat Nano-X Imaging's score of 0.00 indicating that Cytosorbents is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cytosorbents
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Nano-X Imaging
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

32.9% of Cytosorbents shares are owned by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are owned by institutional investors. 7.3% of Cytosorbents shares are owned by insiders. Comparatively, 7.7% of Nano-X Imaging shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Cytosorbents has a net margin of -41.77% compared to Nano-X Imaging's net margin of -472.19%. Nano-X Imaging's return on equity of -30.92% beat Cytosorbents' return on equity.

Company Net Margins Return on Equity Return on Assets
Cytosorbents-41.77% -105.04% -29.18%
Nano-X Imaging -472.19%-30.92%-27.73%

Summary

Cytosorbents beats Nano-X Imaging on 10 of the 16 factors compared between the two stocks.

Get Cytosorbents News Delivered to You Automatically

Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CTSO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CTSO vs. The Competition

MetricCytosorbentsMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$62.61M$10.51B$5.54B$8.95B
Dividend YieldN/A2.09%5.38%4.08%
P/E Ratio-3.7116.7427.4020.04
Price / Sales1.8329.51419.46118.60
Price / CashN/A22.8436.6357.47
Price / Book5.203.668.085.67
Net Income-$20.72M$235.40M$3.16B$248.47M
7 Day Performance-11.86%1.89%2.12%2.90%
1 Month Performance4.00%3.83%4.43%5.75%
1 Year Performance20.93%-10.20%35.62%21.36%

Cytosorbents Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CTSO
Cytosorbents
1.8205 of 5 stars
$1.04
+4.0%
$5.50
+428.8%
+21.7%$62.61M$35.60M-3.71220News Coverage
NNOX
Nano-X Imaging
1.502 of 5 stars
$4.95
-0.8%
$9.50
+91.9%
-22.2%$288.32M$11.28M-5.50190
SNWV
Sanuwave Health
N/A$33.57
-0.3%
N/AN/A$288.15M$32.63M0.0040Positive News
NYXH
Nyxoah
2.4745 of 5 stars
$7.83
+1.6%
$14.50
+85.2%
+7.1%$262.61M$4.89M-3.68110Positive News
Gap Up
ZIMV
ZimVie
2.33 of 5 stars
$8.65
-1.6%
$16.33
+88.8%
-44.8%$244.78M$449.75M-12.181,770
SMTI
Sanara MedTech
1.9751 of 5 stars
$27.82
+2.0%
$49.50
+77.9%
+8.1%$242.46M$86.67M-20.7660
TCMD
Tactile Systems Technology
2.9798 of 5 stars
$10.17
+2.0%
$16.00
+57.3%
-10.5%$231.79M$292.98M15.411,037News Coverage
Positive News
STIM
Neuronetics
1.8243 of 5 stars
$3.43
-0.9%
$5.50
+60.3%
+95.4%$227.74M$74.89M-2.62180
NVRO
Nevro
0.1884 of 5 stars
$5.85
+0.1%
$5.36
-8.3%
-29.9%$224.32M$408.52M-3.091,090
TLSI
TriSalus Life Sciences
2.6482 of 5 stars
$5.29
-5.4%
$10.75
+103.2%
-3.2%$211.52M$29.43M0.00106Gap Down
SGHT
Sight Sciences
0.6731 of 5 stars
$4.34
+6.9%
$4.10
-5.5%
-32.5%$209.88M$79.87M-4.43210

Related Companies and Tools


This page (NASDAQ:CTSO) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners